Background to development of bioeconomy in Ukraine: institutional aspects by V. Lymar, V. Baidala

Get full text

Endothelial activation markers (VCAM-1, vWF) in patients with chronic hepatitis C and insulin resistance by T. V. Antonova, M. A. Romanova, Yu. V. Lymar

Get full text

Endothelial dysfunction markers (VCAM-1, vWF) in chronic hepatitis C by T V Antonova, M A Romanova, Iu V Lymar'

Get full text

Mechanisms of metastasis and development of resistance to therapy in breast cancer. A clinical case of the effectiveness of ixabepilone in hormone-receptorpositive breast cancer wi... by A. I. Stukan, A. Y. Goryainova, S. V. Sharov, D. V. Andreev, E. V. Lymar

Get full text

Molecular features evaluation of metastatic foci as the basis for metastatic breast cancer treatment personalization. Is there a place of CDK4/6-inhibitors in late-line therapy aft... by A. I. Stukan, A. Y. Goryainova, E. V. Lymar, S. V. Sharov, V. V. Antipova

Get full text

Evolution of the CDK4/6 inhibitor abemaciclib: from palliative to adjuvant therapy. Clinical experience with abemaciclib in patients with hormone-receptor-positive, HER2-negative b... by A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, E. V. Lymar

Get full text

Induction of ovarian steroidogenesis as an additional potential risk factor for progression in premenopausal patients with hormone-receptor-positive breast cancer receiving tamoxif... by A. Yu. Goryainova, A. I. Stukan, E. V. Lymar, Z. K. Khachmamuk, I. G. Selezneva

Get full text

Analysis of the clinical efficacy of the cyclin- dependent kinase inhibitor 4/6 Abemaciclib on the clinical case of a male with hormonereceptor- positive breast cancer by А. Y. Goryainova, А. I. Stukan, Е. V. Lymar, S. V. Sharov, R. A. Murashko, D. V. Andreev

Get full text

Role of pre-metastatic niche in organ specificity of breast cancer metastasis. Influence on metastatic potential as a basis for CDK4/6-inhibition efficacy in early therapy of disse... by A. I. Stukan, A. Yu. Goryainova, E. V. Lymar, S. V. Sharov, D. V. Andreev, V. V. Antipova

Get full text

Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibit... by A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, O. I. Kirsanova, E. V. Lymar

Get full text

Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federati... by E. V. Borodavina, P. A. Isaev, A. Yu. Shurinov, P. O. Rumyantsev, V. V. Krylov, K. M. Petrosyan, A. D. Kaprin, S. A. Ivanov, S. O. Podvyaznikov, I. S. Romanov, A. M. Mudunov, K. Yu. Slashchuk, R. S. Zhikhorev, M. V. Volkonsky, R. M. Chagova, I. R. Suslova, A. I. Khryapa, A. Kh. Lepshokova, N. L. Fadeeva, A. R. Safarova, L. P. Kaleykina, E. V. Lymar, E. M. Chernyakova, O. A. Snezhko, A. E. Zinkovskaya, F. F. Mufazalov, E. S. Kuzmina, Yu. V. Druzhinina, Sh. I. Musin, M. R. Mukhitova, A. I. Khasanova, S. Z. Safina, S. L. Kirienko

Get full text